Ghrelin: An orexigenic and somatotrophic signal from the stomach (original) (raw)

• Elmquist, J. K., Maratos-Flier, E., Saper, C. B. & Flier, J. S. Unraveling the central nervous system pathways underlying responses to leptin. Nature Neurosci. 1, 445–450 (1998).
  Article CAS PubMed Google Scholar
• Flier, J. S. & Maratos-Flier, E. Obesity and the hypothalamus: novel peptides for new pathways. Cell 92, 437–440 (1998).
  Article CAS PubMed Google Scholar
• Woods, S. C., Seeley, R. J., Porte, D. Jr & Schwartz, M. W. Signals that regulate food intake and energy homeostasis. Science 280, 1378–1383 (1998).
  Article CAS PubMed Google Scholar
• Bray, G. A. & York, D. A. The MONA LISA hypothesis in the time of leptin. Recent Prog. Horm. Res. 53, 95–117 (1998).
  CAS PubMed Google Scholar
• Friedman, J. M. & Halaas, J. L. Leptin and the regulation of body weight in mammals. Nature 395, 763–770 (1998).
  Article CAS PubMed Google Scholar
• Inui, A. Feeding and body-weight regulation by hypothalamic neuropeptides — mediation of the actions of leptin. Trends Neurosci. 22, 62–67 (1999).
  Article CAS PubMed Google Scholar
• Kalra, S. P. et al. Interacting appetite-regulating pathways in the hypothalamic regulation of body weight. Endocr. Rev. 20, 68–100 (1999).
  CAS PubMed Google Scholar
• Schwartz, M. W., Woods, S. C., Porte, D., Seeley, R. J. & Baskin, D. G. Central nervous system control of food intake. Nature 404, 661–671 (2000).A recent review that provides a summary of hypothalamic effector molecules and neuronal circuits that control food intake and are regulated by leptin and insulin.
  Article CAS PubMed Google Scholar
• Inui, A. Transgenic approach to the study of body weight regulation. Pharmacol. Rev. 52, 35–61 (2000).
  CAS PubMed Google Scholar
• Inui, A. Transgenic study of energy homeostasis equation: implications and confounding influences. FASEB J. 14, 2158–2170 (2000).
  Article CAS PubMed Google Scholar
• Kojima, M. et al. Ghrelin is a growth-hormone-releasing acylated peptide from stomach. Nature 402, 656–660 (1999).Describes the isolation of ghrelin, an endogenous ligand of the growth hormone secretagogue (GHS) receptor, from stomach extracts.
  Article CAS PubMed Google Scholar
• Kojima, M., Hosoda, H., Matsuo, H. & Kangawa, K. Ghrelin: discovery of the natural endogenous ligand for the growth hormone secretagogue receptor. Trends Endocrinol. Metab. 12, 118–122 (2001).
  Article CAS PubMed Google Scholar
• Frohman, L. A. & Jansson, J. O. Growth hormone-releasing hormone. Endocr. Rev. 7, 223–253 (1986).
  Article CAS PubMed Google Scholar
• Frohman, L. A., Downs, T. R. & Chomczynski, P. Regulation of growth hormone secretion. Front. Neuroendocrinol. 13, 344–405 (1992).
  CAS PubMed Google Scholar
• Smith, R. G. et al. Modulation of pulsatile GH release through a novel receptor in hypothalamus and pituitary gland. Recent Prog. Horm. Res. 51, 261–285 (1996).
  CAS PubMed Google Scholar
• Frohman, L. A. et al. Secretagogues and the somatotrope: signaling and proliferation. Recent Prog. Horm. Res. 55, 269–291 (2000).
  CAS PubMed Google Scholar
• Momany, F. A. et al. Design, synthesis, and biological activity of peptides which release growth hormone in vitro. Endocrinology 108, 31–39 (1981).
  Article CAS PubMed Google Scholar
• Bowers, C. Y. et al. Structure–activity relationships of a synthetic pentapeptide that specifically releases growth hormone in vitro. Endocrinology 106, 663–667 (1980).
  Article CAS PubMed Google Scholar
• Bowers, C. Y., Momany, F. A., Reynolds, G. A. & Hong, A. On the in vitro and in vivo activity of a new synthetic hexapeptide that acts on the pituitary to specifically release growth hormone. Endocrinology 114, 1537–1545 (1984).Reports the development of potent GHSs, including growth-hormone-releasing peptide 6 (GHRP-6).
  Article CAS PubMed Google Scholar
• Bowers, C. Y., Sartor, A. A., Reynolds, D. G. & Badger, T. A. M. On the actions of the growth hormone-releasing hexapeptide, GHRP-6. Endocrinology 128, 2027–2035 (1991).
  Article CAS PubMed Google Scholar
• Korbonits, M. & Grossman, A. Growth hormone-releasing peptide and its analogues: novel stimuli to growth hormone release. Trends Endocrinol. Metab. 6, 43–49 (1995).
  Article CAS PubMed Google Scholar
• Smith, R. G. et al. Peptidomimetic regulation of growth hormone secretion. Endocr. Rev. 18, 621–645 (1997).This review summarizes the GHS–GHS receptor system, its control of GH secretion and other physiological functions, as well as its clinical implications.
  Article CAS PubMed Google Scholar
• Casanueva, F. F. & Dieguez, C. Growth hormone secretagogues: physiological role and clinical utility. Trends Endocrinol. Metab. 10, 30–38 (1999).
  Article CAS PubMed Google Scholar
• Guillemin, R. et al. Growth hormone-releasing factor from a human pancreatic tumor that caused acromegaly. Science 218, 585–587 (1982).
  Article CAS PubMed Google Scholar
• Dieguez, C. & Casanueva, F. F. Ghrelin: a step forward in the understanding of somatotroph cell function and growth regulation. Eur. J. Endocrinol. 142, 413–417 (2000).
  Article CAS PubMed Google Scholar
• Patchett, A. A. et al. The design and biological activities of L-163,191 (MK-0677): a potent, orally active growth hormone secretagogue. Proc. Natl Acad. Sci. USA 92, 7001–7005 (1995).
  Article CAS PubMed PubMed Central Google Scholar
• Howard, A. D. et al. A receptor in pituitary and hypothalamus that functions in growth hormone release. Science 273, 974–977 (1996).The first demonstration of a complementary DNA that encodes the GHS receptor by the use of an expression cloning technique.
  Article CAS PubMed Google Scholar
• Dean, D. C. et al. Development of a high specific activity sulfur-35-labeled sulfonamide radioligand that allowed the identification of a new growth hormone secretagogue receptor. J. Med. Chem. 39, 1767–1770 (1996).
  Article CAS PubMed Google Scholar
• Pong, S. S. et al. Identification of a new G-protein-linked receptor for growth hormone secretagogues. Mol. Endocrinol. 10, 57–61 (1996).
  CAS PubMed Google Scholar
• McKee, K. K. et al. Molecular analysis of rat pituitary and hypothalamic growth hormone secretagogue receptors. Mol. Endocrinol. 11, 415–423 (1997).
  Article CAS PubMed Google Scholar
• Guan, X. M. et al. Distribution of mRNA encoding the growth hormone secretagogue receptor in brain and peripheral tissues. Brain Res. Mol. Brain Res. 48, 23–29 (1997).
  Article CAS PubMed Google Scholar
• Chen, C., Wu, D. & Clarke, I. J. Signal transduction systems employed by synthetic GH-releasing peptides in somatotrophs. J. Endocrinol. 148, 381–386 (1996).
  Article CAS PubMed Google Scholar
• Wren, A. M. et al. The novel hypothalamic peptide ghrelin stimulates food intake and growth hormone secretion. Endocrinology 141, 4325–4328 (2000).
  Article CAS PubMed Google Scholar
• Takaya, K. et al. Ghrelin strongly stimulates growth hormone release in humans. J. Clin. Endocrinol. Metab. 85, 4908–4911 (2000).
  Article CAS PubMed Google Scholar
• Date, Y. et al. Central effects of a novel acylated peptide, ghrelin, on growth hormone release in rats. Biochem. Biophys. Res. Commun. 275, 477–480 (2000).
  Article CAS PubMed Google Scholar
• Seoane, L. M. Ghrelin elicites a marked stimulatory effect on GH secretion in freely-moving rats. Eur. J. Endocrinol. 143, R7–9 (2000).
  Article CAS PubMed Google Scholar
• Peino, R. et al. Ghrelin-induced growth hormone secretion in humans. Eur. J. Endocrinol. 143, R11–14 (2000).
  Article CAS PubMed Google Scholar
• Bednarek, M. A. et al. Structure–function studies on the new growth hormone-releasing peptide, ghrelin: minimal sequence of ghrelin necessary for activation of growth hormone secretagogue receptor 1a. J. Med. Chem. 43, 4370–4376 (2000).
  Article CAS PubMed Google Scholar
• Rehfeld, J. F. The new biology of gastrointestinal hormones. Physiol. Rev. 78, 1087–1108 (1998).
  Article CAS PubMed Google Scholar
• Hosoda, H., Kojima, M., Matsuo, H. & Kangawa, K. Purification and characterization of rat des-Gln14-ghrelin, a second endogenous ligand for the growth hormone secretagogue receptor. J. Biol. Chem. 275, 21995–22000 (2000).
  Article CAS PubMed Google Scholar
• Gualillo, O. et al. Ghrelin, a novel placental-derived hormone. Endocrinology 142, 788–794 (2001).
  Article CAS PubMed Google Scholar
• Tullin, S. et al. Adenosine is an agonist of the growth hormone secretagogue receptor. Endocrinology 141, 3397–3402 (2000).
  Article CAS PubMed Google Scholar
• Smith, R. G. et al. Adenosine: a partial agonist of the growth hormone secretagogue receptor. Biochem. Biophys. Res. Commun. 276, 1306–1313 (2000).
  Article CAS PubMed Google Scholar
• Tomasetto, C. et al. Identification and characterization of a novel gastric peptide hormone: the motilin-related peptide. Gastroenterology 119, 395–405 (2000).Identifies a novel cDNA from the stomach that encodes a protein named prepromotilin-related peptide (on the basis of its sequence similarity to prepromotilin).
  Article CAS PubMed Google Scholar
• Itoh, Z. Motilin and clinical application. Peptides 18, 593–608 (1997).
  Article CAS PubMed Google Scholar
• Peeters, T. L. Erythromycin and other macrolides as prokinetic agents. Gastroenterology 105, 1886–1899 (1993).
  Article CAS PubMed Google Scholar
• Asakawa, A. et al. Ghrelin is an appetite-stimulatory signal from stomach with structual resemblance to motilin. Gastroenterology 120, 337–345 (2001).Ghrelin is the first appetite-stimulatory signal to be isolated from the stomach, and is the motilin-related peptide described in reference 44.
  Article CAS PubMed Google Scholar
• Del Rincon, J. P., Thorner, M. O. & Gaylinn, B. D. Motilin-related peptide and ghrelin: lessons from molecular techniques, peptide chemistry, and receptor biology. Gastroenterology 120, 587–588 (2001).
  Article CAS PubMed Google Scholar
• Coulie, B. J. & Miller, L. J. Identification of motilin-related peptide. Gastroenterology 120, 588–589 (2001).
  Article CAS PubMed Google Scholar
• Feighner, S. D. et al. Receptor for motilin identified in the human gastrointestinal system. Science 284, 2184–2188 (1999).
  Article CAS PubMed Google Scholar
• Thielemans, L., Depoortere, I., Assche, G. V., Bender, E. & Peeters, T. L. Demonstration of a functional motilin receptor in TE671 cells from human cerebellum. Brain Res. 895, 119–128 (2001).
  Article CAS PubMed Google Scholar
• Samson, W. K., Lumpkin, M. D., Nilaver, G. & McCann, S. M. Motilin: a novel growth hormone releasing agent. Brain Res. Bull. 12, 57–62 (1984).
  Article CAS PubMed Google Scholar
• Date, Y. et al. Ghrelin, a novel growth hormone-releasing acylated peptide, is synthesized in a distinct endocrine cell type in the gastrointestinal tracts of rats and humans. Endocrinology 141, 4255–4261 (2000).
  Article CAS PubMed Google Scholar
• Hosoda, H., Kojima, M., Matsuo, H. & Kangawa, K. Ghrelin and des-acyl ghrelin: two major forms of rat ghrelin peptide in gastrointestinal tissue. Biochem. Biophys. Res. Commun. 279, 909–913 (2001).
  Article CAS Google Scholar
• Depoortere, I., De Clercq, P., Svoboda, M., Bare, L. & Peeters, T. L. Identification of motilin mRNA in the brain of man and rabbit. Conservation of polymorphism of the motilin gene across species. Peptides 10, 1497–1503 (1997).
  Article Google Scholar
• Okada, K. et al. Intracerebroventricular administration of the growth hormone-releasing peptide KP-102 increases food intake in free-feeding rats. Endocrinology 137, 5155–5158 (1996).
  Article CAS PubMed Google Scholar
• Torsello, A. et al. Novel hexarelin analogs stimulate feeding in the rat through a mechanism not involving growth hormone release. Eur. J. Pharmacol. 360, 123–129 (1998).
  Article CAS PubMed Google Scholar
• Locke, W., Kirgis, H. D., Bowers, C. Y. & Abdoh, A. A. Intracerebroventricular growth-hormone-releasing peptide-6 stimulates eating without affecting plasma growth hormone responses in rats. Life Sci. 56, 1347–1352 (1995).
  Article CAS PubMed Google Scholar
• Ghigo, E. et al. Endocrine and non-endocrine activities of growth hormone secretagogues in humans. Horm. Res. 51, 9–15 (1999).
  CAS PubMed Google Scholar
• Tschöp, M., Smiley, D. L. & Heiman, M. L. Ghrelin induces adiposity in rodents. Nature 407, 908–913 (2000).Indicates an involvement of ghrelin in the regulation of energy balance by showing that ghrelin causes weight gain by reducing fat use.
  Article PubMed Google Scholar
• Nakazato, M. et al. A role for ghrelin in the central regulation of feeding. Nature 409, 194–198 (2001).Ghrelin is a physiological mediator of feeding and acts through neuropeptide Y and agouti-related protein in the hypothalamus.
  Article CAS PubMed Google Scholar
• Shintani, M. et al. Ghrelin, an endogenous growth hormone secretagogue, is a novel orexigenic peptide that antagonizes leptin action through the activation of hypothalamic neuropeptide Y/Y1 receptor pathway. Diabetes 50, 227–232 (2001).
  Article CAS PubMed Google Scholar
• Hewson, A. K. & Dickson, S. L. Systemic administration of ghrelin induces Fos and Egr-1 proteins in the hypothalamic arcuate nucleus of fasted and fed rats. J. Neuroendocrinol. 12, 1047–1049 (2000).
  Article CAS PubMed Google Scholar
• Hirosue, Y. et al. Cholecystokinin octapeptide analogues suppress food intake via central CCK-A receptors in mice. Am. J. Physiol. 265, R481–486 (1993).
  CAS PubMed Google Scholar
• Smith, G. P. & Gibbs, J. Satiating effect of cholecystokinin. Ann. NY Acad. Sci. 713, 236–241 (1994).
  Article CAS PubMed Google Scholar
• Moran, T. H. Cholecystokinin and satiety: current perspectives. Nutrition 16, 858–865 (2000).
  Article CAS PubMed Google Scholar
• Schwartz, G. J. The role of gastrointestinal vagal afferents in the control of food intake: current prospects. Nutrition 16, 866–873 (2000).
  Article CAS PubMed Google Scholar
• Yoshida-Yoneda, E., O-Lee, T. J., Wei, J. Y., Vigna, S. R. & Tache, Y. Peripheral bombesin induces gastric vagal afferent activation in rats. Am. J. Physiol. 271, R1584–1593 (1996).
  CAS PubMed Google Scholar
• Kurosawa, M., Uvnas, M. K., Miyasaka, K. & Lundeberg, T. Interleukin-1 increases activity of the gastric vagal afferent nerve partly via stimulation of type A CCK receptor in anesthetized rats. J. Auton. Nerv. Syst. 12, 72–78 (1997).
  Article Google Scholar
• Wang, Y. H., Tache, Y., Sheibel, A. B., Go, V. L. & Wei, J. Y. Two types of leptin-responsive gastric vagal afferent terminals: an in vitro single-unit study in rats. Am. J. Physiol. 273, R833–837 (1997).
  CAS PubMed Google Scholar
• Masuda, Y. et al. Ghrelin stimulates gastric acid secretion and motility in rats. Biochem. Biophys. Res. Commun. 276, 905–908 (2000).
  Article CAS PubMed Google Scholar
• Morley, J. E. Neuropeptide regulation of appetite and weight. Endocr. Rev. 8, 256–287 (1987).
  Article CAS PubMed Google Scholar
• Zhang, Y. et al. Positional cloning of the mouse obese gene and its human homologue. Nature 372, 425–432 (1994).
  Article CAS PubMed Google Scholar
• Baskin, D. G., Breininger, J. F. & Schwartz, M. W. Leptin receptor mRNA identifies a subpopulation of neuropeptide Y neurons activated by fasting in rat hypothalamus. Diabetes 48, 828–833 (1999).
  Article CAS PubMed Google Scholar
• Cheung, C. C., Clifton, D. K. & Steiner, R. A. Proopiomelanocortin neurons are direct targets for leptin in the hypothalamus. Endocrinology 138, 4489–4492 (1997).
  Article CAS PubMed Google Scholar
• Campfield, L. A., Smith, F. J., Guisez, Y., Devos, R. & Burn, P. Recombinant mouse OB protein: evidence for a peripheral signal linking adiposity and central neural networks. Science 269, 546–549 (1995).
  Article CAS PubMed Google Scholar
• Schwartz, M. W., Figlewicz, D. P., Baskin, D. G., Woods, S. C. & Porte, D. Jr Insulin in the brain: a hormonal regulator of energy balance. Endocr. Rev. 13, 387–414 (1992).
  CAS PubMed Google Scholar
• Ahima, R. S. & Flier, J. S. Leptin. Annu. Rev. Physiol. 62, 413–437 (2000).
  Article CAS PubMed Google Scholar
• Sawchenko, P. E. Toward a new neurobiology of energy balance, appetite, and obesity: the anatomists weigh in. J. Comp. Neurol. 402, 435–441 (1998).
  Article CAS PubMed Google Scholar
• Elmquist, J. K., Elias, C. F. & Saper, C. B. From lesions to leptin: hypothalamic control of food intake and body weight. Neuron 22, 221–232 (1999).
  Article CAS PubMed Google Scholar
• Satoh, N. et al. The arcuate nucleus as a primary site of satiety effect of leptin in rats. Neurosci. Lett. 224, 149–152 (1997).
  Article CAS PubMed Google Scholar
• Tang-Christensen, M., Holst, J. J., Hartmann, B. & Vrang, N. The arcuate nucleus is pivotal in mediating the anorectic effects of centrally administered leptin. Neuroreport 10, 1183–1187 (1999).
  Article CAS PubMed Google Scholar
• Dawson, R., Pelleymounter, M. A., Millard, W. J., Liu, S. & Eppler, B. Attenuation of leptin-mediated effects by monosodium glutamate-induced arcuate nucleus damage. Am. J. Physiol. 273, E202–206 (1997).
  CAS PubMed Google Scholar
• Tartaglia, L. A. et al. Identification and expression cloning of a leptin receptor, OB-R. Cell 83, 1263–1271 (1995).
  Article CAS PubMed Google Scholar
• Tartaglia, L. A. The leptin receptor. J. Biol. Chem. 272, 6093–6096 (1997).
  Article CAS PubMed Google Scholar
• Hahn, T. M., Breininger, J. F., Baskin, D. G. & Schwartz, M. W. Coexpression of Agrp and NPY in fasting-activated hypothalamic neurons. Nature Neurosci. 1, 271–272 (1998).
  Article CAS PubMed Google Scholar
• Broberger, C., Johansen, J., Johansson, C., Schalling, M. & Hökfelt, T. The neuropeptide Y/agouti gene-related protein (AGRP) brain circuitry in normal, anorectic, and monosodium glutamate-treated mice. Proc. Natl Acad. Sci. USA 95, 15043–15048 (1998).
  Article CAS PubMed PubMed Central Google Scholar
• Elias, C. F. et al. Leptin activates hypothalamic CART neurons projecting to the spinal cord. Neuron 21, 1375–1385 (1998).
  Article CAS PubMed Google Scholar
• Ollmann, M. M. et al. Antagonism of central melanocortin receptors in vitro and in vivo by agouti-related protein. Science 278, 135–138 (1997).
  Article CAS PubMed Google Scholar
• Shutter, J. R. et al. Hypothalamic expression of ART, a novel gene related to agouti, is up-regulated in obese and diabetic mutant mice. Genes Dev. 11, 593–602 (1997).
  Article CAS PubMed Google Scholar
• Fan, W., Boston, B. A., Kesterson, R. A., Hruby, V. J. & Cone, R. D. Role of melanocortinergic neurons in feeding and the agouti obesity syndrome. Nature 385, 165–168 (1997).
  Article CAS PubMed Google Scholar
• Stephens, T. W. et al. The role of neuropeptide Y in the antiobesity action of the obese gene product. Nature 377, 530–532 (1995).
  Article CAS PubMed Google Scholar
• Kristensen, P. et al. Hypothalamic CART is a new anorectic peptide regulated by leptin. Nature 393, 72–76 (1998).
  Article CAS PubMed Google Scholar
• Schwartz, M. W. et al. Leptin increases hypothalamic pro-opiomelanocortin mRNA expression in the rostral arcuate nucleus. Diabetes 46, 2119–2123 (1997).
  Article CAS PubMed Google Scholar
• Thornton, J. E., Cheung, C. C., Clifton, D. K., & Steiner, R. A. Regulation of hypothalamic proopiomelanocortin mRNA by leptin in ob/ob mice. Endocrinology 138, 5063–5066 (1997).
  Article CAS PubMed Google Scholar
• Cowley, M. A. et al. Integration of NPY, AGRP, and melanocortin signals in the hypothalamic paraventricular nucleus: evidence of a cellular basis for the adipostat. Neuron 24, 155–163 (1999).
  Article CAS PubMed Google Scholar
• Kalra, S. P., Dube, M. G., Sahu, A., Phelps, C. P. & Kalra, P. S. Neuropeptide Y secretion increases in the paraventricular nucleus in association with increased appetite for food. Proc. Natl Acad. Sci. USA 88, 10931–10935 (1991).
  Article CAS PubMed PubMed Central Google Scholar
• Dickson, S. L., Leng, G. & Robinson, I. C. Systemic administration of growth hormone-releasing peptide activates hypothalamic arcuate neurons. Neuroscience 53, 303–306 (1993).
  Article CAS PubMed Google Scholar
• Kamegai, J., Hasegawa, O., Minami, S., Sugihara, H. & Wakabayashi, I. The growth hormone-releasing peptide KP-102 induces c-fos expression in the arcuate nucleus. Brain Res. Mol. Brain Res. 39, 153–159 (1996).
  Article CAS PubMed Google Scholar
• Willesen, M. G., Kristensen, P. & Romer, J. Co-localization of growth hormone secretagogue receptor and NPY mRNA in the arcuate nucleus of the rat. Neuroendocrinology 70, 306–316 (1999).
  Article CAS PubMed Google Scholar
• Kamegai, J. et al. Central effect of ghrelin, an endogenous growth hormone secretagogue, on hypothalamic peptide gene expression. Endocrinology 141, 4797–4800 (2000).
  Article CAS PubMed Google Scholar
• Torsello, A. et al. Differential orexigenic effects of hexarelin and its analogs in the rat hypothalamus: indication for multiple growth hormone secretagogue receptor subtypes. Neuroendocrinology 72, 327–332 (2000).
  Article CAS PubMed Google Scholar
• Inui, A. Neuropeptide Y feeding receptors: are multiple subtypes involved? Trends Pharmacol. Sci. 20, 43–46 (1999).
  Article CAS PubMed Google Scholar
• Herzog, H. Y4 receptor deletion improves fertility in ob/ob mice without affecting the obese phenotype. Proc. VIth Int. Neuropeptide Y Conf. 06 (2001).
• Naveilhan, P. et al. Normal feeding behavior, body weight and leptin response require the neuropeptide Y Y2 receptor. Nature Med. 5, 1188–1193 (1999).
  Article CAS PubMed Google Scholar
• Sainsbury, A., Couzens, M., Lui, M. & Herzog, H. Critical role of Y2 receptors in body weight regulation revealed by adult-induced arcuate-specific gene deletion. Proc. VIth Int. Neuropeptide Y Conf. 014 (2001).
• Hagan, M. M. et al. Long-term orexigenic effects of AGRP-(83-132) involve mechanisms other than melanocortin receptor blockade. Am. J. Physiol. 279, R47–52 (2000).
  CAS Google Scholar
• Hagan, M. M., Rushing, P. A., Benoit, S. C., Woods, S. C. & Seeley, R. J. Opioid receptor involvement in the effect of AgRP- (83-132) on food intake and food selection. Am. J. Physiol. 280, R814–821 (2001).
  Article CAS Google Scholar
• Erickson, J. C., Clegg, K. E. & Palmiter, R. D. Sensitivity to leptin and susceptibility to seizures of mice lacking neuropeptide Y. Nature 381, 415–421 (1996).
  Article CAS PubMed Google Scholar
• Kohno, D. & Yada, T. Ghrelin increases cytosolic Ca2+ in the hypothalamic arcuate nucleus neurons. Jpn. J. Physiol. 51 (in the press).
• Cowley, M. A. et al. Leptin activates anorexigenic POMC neurons through a neural network in the arcuate nucleus. Nature 411, 480–484 (2001).
  Article CAS PubMed Google Scholar
• Toshinai, K. et al. Upregulation of ghrelin expression in the stomach upon fasting, insulin-induced hypoglycemia, and leptin administration. Biochem. Biophys. Res. Commun. 281, 1220–1225 (2001).
  Article CAS PubMed Google Scholar
• Bado, A. et al. The stomach is a source of leptin. Nature 394, 790–793 (1998).Reports the presence of leptin in the stomach; this hormone is probably involved in CCK-mediated effects, including satiety.
  Article CAS PubMed Google Scholar
• Barrachina, M. D., Martinez, V., Wang, L., Wei, J. Y. & Tache, Y. Synergistic interaction between leptin and cholecystokinin to reduce short-term food intake in lean mice. Proc. Natl Acad. Sci. USA 94, 10455–10460 (1997).
  Article CAS PubMed PubMed Central Google Scholar
• Matson, C. A. & Ritter, R. C. Long-term CCK–leptin synergy suggests a role for CCK in the regulation of body weight. Am. J. Physiol. 276, R1038–1045 (1999).
  Article CAS PubMed Google Scholar
• Tolle, V. et al. In vivo and in vitro effects of ghrelin/motilin-related peptide on growth hormone secretion in the rat. Neuroendocrinology 73, 54–61 (2001).
  Article CAS PubMed Google Scholar
• Minami, S., Kamegai, J., Sugihara, H., Suzuki, N. & Wakabayashi, I. Growth hormone inhibits its own secretion by acting on the hypothalamus through its receptors on neuropeptide Y neurons in the arcuate nucleus and somatostatin neurons in the periventricular nucleus. Endocr. J. 45, S19–26 (1998).
  Article CAS PubMed Google Scholar
• Bowers, C. Y. Unnatural growth hormone-releasing peptide begets natural ghrelin. J. Clin. Endocrinol. Metab. 86, 1464–1469 (2001).
  Article CAS PubMed Google Scholar
• Korbonits, M. et al. The expression of the growth hormone secretagogue receptor ligand ghrelin in normal and abnormal human pituitary and other neuroendocrine tumors. J. Clin. Endocrinol. Metab. 86, 881–887 (2001).
  CAS PubMed Google Scholar
• Chapman, I. M. et al. Stimulation of the growth hormone (GH)-insulin-like growth factor-I axis by daily oral administration of a GH secretagogue (MK-0677) in healthy elderly subjects. J. Clin. Endocrinol. Metab. 81, 4249–4257 (1996).
  CAS PubMed Google Scholar
• Ghigo, E. et al. Biologic activities of growth hormone secretagogues in humans. Endocrine 14, 87–93 (2001).
  Article CAS PubMed Google Scholar
• Dieguez, C. & Casanueva, F. F. Influence of metabolic substrates and obesity on growth hormone secretion. Trends Endocrinol. Metab. 6, 55–59 (1995).
  Article CAS PubMed Google Scholar
• Tschöp, M. et al. Circulating ghrelin levels are decreased in human obesity. Diabetes 50, 707–709 (2001).
  Article PubMed Google Scholar
• Levin, B. E. & Keesey, R. E. Defense of differing body weight set points in diet-induced obese and resistant rats. Am. J. Physiol. 274, R412–419 (1998).
  CAS PubMed Google Scholar
• Levin, B. E. Arcuate NPY neurons and energy homeostasis in diet-induced obese and resistant rats. Am. J. Physiol. 276, R382–387 (1999).
  CAS PubMed Google Scholar
• Kaga, T. et al. Modest overexpression of NPY in the brain leads to obesity after high sucrose feeding. Diabetes 50, 1206–1210 (2001).
  Article CAS PubMed Google Scholar
• Ziotopoulou, M., Mantzoros, C. S., Hileman, S. M. & Flier, J. S. Differental expression of hypothalamic neuropeptides in the early phase of diet-induced obesity in mice. Am. J. Physiol. 279, E838–845 (2000).
  CAS Google Scholar
• Flier, J. S. Clinical review 94: what's in a name? In search of leptin's physiologic role. J. Clin. Endocrinol. Metab. 83, 1407–1413 (1998).
  CAS PubMed Google Scholar
• Ahima, R. S. et al. Role of leptin in the neuroendocrine response to fasting. Nature 382, 250–252 (1996).
  Article CAS PubMed Google Scholar
• Bray, G. A. & York, D. A. Hypothalamic and genetic obesity in experimental animals: an autonomic and endocrine hypothesis. Physiol. Rev. 59, 719–790 (1979).
  Article CAS PubMed Google Scholar
• Schwartz, M. W., Dallman, M. F. & Woods, S. C. Hypothalamic response to starvation: implications for the study of wasting disorders. Am. J. Physiol. 269, R949–957 (1995).
  CAS PubMed Google Scholar
• Inui, A. Cancer anorexia–cachexia syndrome: are neuropeptides the key? Cancer Res. 59, 4493–4501 (1999).
  CAS PubMed Google Scholar
• Plata-Salaman, C. R. Central nervous system mechanisms contributing to the cachexia–anorexia syndrome. Nutrition 16, 1009–1012 (2000).
  Article CAS PubMed Google Scholar
• Inui, A. Cytokine and sickness behavior: implications from knockout animal models. Trends Immunol. (in the press).
• Gayle, D., Ilyin, S. E. & Plata-Salaman, C. R. Central nervous system IL-1 beta system and neuropeptide Y mRNAs during IL-1 beta-induced anorexia in rats. Brain Res. Bull. 44, 311–317 (1997).
  Article CAS PubMed Google Scholar
• Welle, S. Growth hormone and insulin-like growth factor-I as anabolic agents. Curr. Opin. Clin. Nutr. Metab. Care 1, 257–262 (1998).
  Article CAS PubMed Google Scholar
• Van den Berghe, G. Novel insights into the neuroendocrinology of critical illness. Eur. J. Endocrinol. 143, 1–13 (2000).
  Article CAS PubMed Google Scholar
• Murphy, M. G. et al. MK-677, an orally active growth hormone secretagogue, reverses diet-induced catabolism. J. Clin. Endocrinol. Metab. 83, 320–325 (1998).
  CAS PubMed Google Scholar
• Van den Berghe, G. et al. Neuroendocrinology of prolonged critical illness: effects of exogenous thyrotropin-releasing hormone and its combination with growth hormone secretagogues. J. Clin. Endocrinol. Metab. 83, 309–319 (1998).
  CAS PubMed Google Scholar
• Hansen, B. S. et al. Pharmacological characterisation of a new oral GH secretagogue, NN703. Eur. J. Endocrinol. 141, 180–189 (1999).
  Article CAS PubMed Google Scholar
• Leibowitz, S. F. Brain peptides and obesity: pharmacologic treatment. Obes. Res. 3, 573S–589S (1995).
  Article CAS PubMed Google Scholar
• Levine, A. S. & Billington, C. J. Obesity: progress through genetic manipulation. Curr. Biol. 8, R251–252 (1998).
  Article CAS PubMed Google Scholar